United States NSAIDs Market was valued at USD 10.86 Billion in 2022 and is projected to reach USD 14.29 Billion by 2030, growing at a CAGR of 3.5% from 2024 to 2030.
The US NSAIDs (Nonsteroidal Anti-Inflammatory Drugs) market plays a crucial role in the healthcare sector, providing essential treatments for pain relief, inflammation, and fever reduction. These drugs are commonly used in various industries such as pharmaceuticals, healthcare, and consumer goods. In the US, the NSAIDs market is experiencing significant growth, driven by an increasing demand for effective over-the-counter (OTC) and prescription pain relief solutions.
NSAIDs are available in different forms, including oral tablets, topical creams, gels, and injectables. The most common types of NSAIDs include ibuprofen, naproxen, aspirin, and diclofenac. These drugs are widely used across diverse industries such as healthcare, sports medicine, and geriatrics due to their pain-relieving properties and their ability to reduce inflammation. In recent years, the demand for NSAIDs has surged due to a growing awareness of their benefits, especially among older adults and those with chronic pain conditions.
Industries like pharmaceuticals rely heavily on NSAIDs to manufacture medications for various ailments, including arthritis, muscle pain, and post-surgical recovery. Healthcare providers, such as hospitals and clinics, also require NSAIDs to treat patients with acute or chronic pain. Additionally, the growing interest in wellness products has led to the development of OTC NSAIDs, which are easily accessible for the general population to manage minor pain and inflammation without needing a prescription.
As industries seek more advanced and effective pain management solutions, the NSAIDs market continues to evolve. Companies are focusing on improving the safety and efficacy of these drugs, with efforts to reduce side effects commonly associated with prolonged NSAID use, such as gastrointestinal issues and cardiovascular risks. The growing requirement for NSAIDs in various industries, especially in the aging population, is likely to drive market demand for the foreseeable future, shaping the trajectory of the US NSAIDs market.
Despite challenges, such as regulatory hurdles and the competition from alternative treatments, the NSAIDs market remains vital in providing accessible pain management solutions. The industry’s growth can be attributed to the ongoing demand for these drugs in both consumer and medical settings, making NSAIDs an integral part of modern healthcare practices in the US.
Get an In-Depth Research Analysis of the US NSAIDs Market Size And Forecast [2025-2032]
Bayer (DE)
Novacap (FR)
Abbott
Pfizer Inc Geri-Care Pharmaceuticals
Perrigo Company
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US NSAIDs Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US NSAIDs Market
Non-selective NSAIDs
Selective COX-2 inhibitors
Combination products
Oral
Topical
Injectable
Osteoarthritis
Rheumatoid arthritis
Acute pain
Chronic pain
Dysmenorrhea
Pharmacy Stores
Online Pharmacies
Hospitals
Retail Stores
Healthcare Providers
Patients
Long-term Care Facilities
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ NSAIDs Market Research Analysis
1. Introduction of the US NSAIDs Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US NSAIDs Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US NSAIDs Market, By Type
6. US NSAIDs Market, By Application
7. US NSAIDs Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US NSAIDs Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/